San Diego biotech starts clin­i­cal study of self-repli­cat­ing RNA vac­cine for ra­bies

Repli­cate Bio­science, a biotech start­up de­sign­ing next-gen­er­a­tion mR­NA vac­cines to trig­ger stronger and longer-last­ing im­mune re­spons­es, has be­gun its first clin­i­cal study, the San Diego …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER